Cargando…

Circulating T Follicular Helper Cell Abnormalities Associated to Different Clinical Forms of Chronic Chagas Disease

Multiple perturbations of the immune response affecting a range of cells have been reported in Trypanosoma cruzi-infected individuals and associated to clinical manifestations of chronic Chagas disease. There is a paucity of knowledge about the role of T follicular helper (Tfh) cells in this infecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quebrada Palacio, Luz P., Fernández, Esteban R., Hernández-Vásquez, Yolanda, Petray, Patricia B., Postan, Miriam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136390/ https://www.ncbi.nlm.nih.gov/pubmed/32296649 http://dx.doi.org/10.3389/fcimb.2020.00126

Ejemplares similares

Phenotypic diversity and drug susceptibility of Trypanosoma cruzi TcV clinical isolates
por: Quebrada Palacio, Luz P., et al.
Publicado: (2018)

Trypanosoma cruzi Induces Regulatory B Cell Alterations in Patients With Chronic Chagas Disease
por: Girard, Magalí C., et al.
Publicado: (2021)

The Differentiation and Maintenance of SARS-CoV-2-Specific Follicular Helper T Cells
por: Wang, Yifei, et al.
Publicado: (2022)

Circulating MicroRNAs and myocardial involvement severity in chronic Chagas cardiomyopathy
por: Gómez-Ochoa, Sergio Alejandro, et al.
Publicado: (2022)

Altered Distribution of Peripheral Blood Memory B Cells in Humans Chronically Infected with Trypanosoma cruzi
por: Fernández, Esteban R., et al.
Publicado: (2014)

Elevated Serum Levels of Macrophage Migration Inhibitory Factor Are Associated with Progressive Chronic Cardiomyopathy in Patients with Chagas Disease
por: Cutrullis, Romina A., et al.
Publicado: (2013)

Cruzipain Sulfotopes-Specific Antibodies Generate Cardiac Tissue Abnormalities and Favor Trypanosoma cruzi Infection in the BALB/c Mice Model of Experimental Chagas Disease
por: Soprano, Luciana L., et al.
Publicado: (2022)

Editorial: World Chagas disease day 2022
por: Palmisano, Giuseppe, et al.
Publicado: (2023)

Anti-inflammatory Role of Galectin-8 During Trypanosoma cruzi Chronic Infection
por: Bertelli, Adriano, et al.
Publicado: (2020)

Discovery and Genetic Validation of Chemotherapeutic Targets for Chagas' Disease
por: Osorio-Méndez, Juan Felipe, et al.
Publicado: (2019)

Editorial: Chagas disease novel drug targets and treatments
por: Duschak, Vilma G., et al.
Publicado: (2023)

Precision Health for Chagas Disease: Integrating Parasite and Host Factors to Predict Outcome of Infection and Response to Therapy
por: Martinez, Santiago J., et al.
Publicado: (2020)

Gut Dysbiosis in Chagas Disease. A Possible Link to the Pathogenesis
por: de Souza-Basqueira, Marcela, et al.
Publicado: (2020)

T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression
por: Gil-Etayo, Francisco Javier, et al.
Publicado: (2021)

Air Pollution’s Impact on Cardiac Remodeling in an Experimental Model of Chagas Cardiomyopathy
por: Fonseca, Keila Cardoso Barbosa, et al.
Publicado: (2022)

Role of the Complement System in the Modulation of T-Cell Responses in Chronic Chagas Disease
por: Caputo, María Belén, et al.
Publicado: (2022)

Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases?
por: Scariot, Debora B., et al.
Publicado: (2022)

Bob1 limits cellular frequency of T‐follicular helper cells
por: Yamashita, Keiji, et al.
Publicado: (2016)

Archaea Symbiont of T. cruzi Infection May Explain Heart Failure in Chagas Disease
por: Higuchi, Maria de Lourdes, et al.
Publicado: (2018)

Sirtuin Control of Mitochondrial Dysfunction, Oxidative Stress, and Inflammation in Chagas Disease Models
por: Wan, Xianxiu, et al.
Publicado: (2021)

Trypanosoma cruzi trans-Sialidase as a Potential Vaccine Target Against Chagas Disease
por: da Costa, Kelli Monteiro, et al.
Publicado: (2021)

The Search for Biomarkers and Treatments in Chagas Disease: Insights From TGF-Beta Studies and Immunogenetics
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2022)

Does Autoimmunity Play a Role in the Immunopathogenesis of Vasculitis Associated With Chronic Chagas Disease?
por: Garcia-Bustos, Victor, et al.
Publicado: (2021)

Immunomodulation for the Treatment of Chronic Chagas Disease Cardiomyopathy: A New Approach to an Old Enemy
por: Santos, Emanuelle de Souza, et al.
Publicado: (2021)

Chagas Immunochromatographic Rapid Test in the Serological Diagnosis of Trypanosoma cruzi Infection in Wild and Domestic Canids
por: Rodrigues, Esthefany S., et al.
Publicado: (2022)

Trypanosoma Species in Small Nonflying Mammals in an Area With a Single Previous Chagas Disease Case
por: Dario, Maria Augusta, et al.
Publicado: (2022)

Hallmarks of the relationship between host and Trypanosoma cruzi sulfated glycoconjugates along the course of Chagas disease
por: Soprano, Luciana L., et al.
Publicado: (2023)

Differential Expression of Immune Response Genes in Asymptomatic Chronic Chagas Disease Patients Versus Healthy Subjects
por: Gómez, Inmaculada, et al.
Publicado: (2021)

Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy
por: Farani, Priscila Silva Grijó, et al.
Publicado: (2021)

The Role of the Na(+)/Ca(2+) Exchanger in Aberrant Intracellular Ca(2+) in Cardiomyocytes of Chagas-Infected Rodents
por: Lopez, Jose R., et al.
Publicado: (2022)

Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease
por: Jones, Kathryn M., et al.
Publicado: (2023)

Knowledge, attitudes, behaviors, and serological status related to Chagas disease among Latin American migrants in Germany: A cross-sectional study in six German cities
por: Wirth, Margit, et al.
Publicado: (2023)

Characterization and Follow-Up of Trypanosoma cruzi Natural Populations Refractory to Etiological Chemotherapy in Oral Chagas Disease Patients
por: Muñoz-Calderón, Arturo, et al.
Publicado: (2021)

Fenofibrate Increases the Population of Non-Classical Monocytes in Asymptomatic Chagas Disease Patients and Modulates Inflammatory Cytokines in PBMC
por: Pieralisi, Azul V., et al.
Publicado: (2022)

In Chagas disease, transforming growth factor beta neutralization reduces Trypanosoma cruzi infection and improves cardiac performance
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2022)

The circulating life of a memory T-follicular helper cell
por: Ma, Cindy S, et al.
Publicado: (2017)

The circulating life of a memory T-follicular helper cell
por: Ma, Cindy S, et al.
Publicado: (2017)

The link between circulating follicular helper T cells and autoimmunity
por: Walker, Lucy S. K.
Publicado: (2022)

The repositioned drugs disulfiram/diethyldithiocarbamate combined to benznidazole: Searching for Chagas disease selective therapy, preventing toxicity and drug resistance
por: Almeida-Silva, Juliana, et al.
Publicado: (2022)

Trypanosoma cruzi-specific CD8(+) T cells and other immunological hallmarks in chronic Chagas cardiomyopathy: Two decades of research
por: Puerta, Concepción J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_13o0338c4rs2g6itrfvj3sjt1e